Filing Details

Accession Number:
0000921895-16-004769
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-06-01 16:45:04
Reporting Period:
2016-05-27
Filing Date:
2016-06-01
Accepted Time:
2016-06-01 16:45:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
707388 Digirad Corp DRAD Electromedical & Electrotherapeutic Apparatus (3845) 330145723
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1538979 G. Matthew Molchan 1048 Industrial Court
Suwanee GA 30024
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-05-27 11,666 $1.21 38,166 No 4 M Direct
Common Stock Disposition 2016-05-27 5,833 $5.01 32,333 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2016-05-27 11,666 $0.00 11,666 $1.21
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2016-07-09 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.0125, inclusive. The reporting person undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price such shares were sold.
  2. Fifty percent (50%) of the shares subject to the option vested and became exercisable on the one year anniversary of the grant date of the option (July 9, 2009), and one twenty-fourth (1/24th) of the shares subject to the option vested and became exercisable monthly thereafter, such that all the shares subject to the option were vested and exercisable on the second anniversary of the grant date, subject to the reporting person's continuous service through each such date.